Literature DB >> 28324326

The Impact of Fabry Disease on Reproductive Fitness.

Dawn A Laney1, Virginia Clarke2, Allison Foley3, Eric W Hall4, Scott E Gillespie5, Myrl Holida6, Morgan Simmons3, Alexandrea Wadley7.   

Abstract

Fabry disease (FD) is a pan-ethnic, X-linked, progressive lysosomal storage disorder caused by pathogenic mutations in the GLA gene. Published case reports and abstracts suggest that decreased reproductive fitness may occur in males with FD. In order to understand the impact of FD on reproductive fitness and increase the accuracy of reproductive genetic counseling, this study examines a large, multi-centered population of individuals with FD to determine if males have reduced reproductive fitness. Study data were collected on 376 patients through two, gender-specific surveys distributed across the United States and Canada. The number of biological live-born children among individuals with FD was compared to statistics from the general population. Information was also collected on reduced sperm count, depression, pain, use of assisted reproductive technology, and reproductive choice. On average, females affected by FD had more biological live-born children (1.8) than males affected by FD (1.1). However, males affected by FD had an increased mean number of biological children (1.1) compared to the mean number of biological children fathered by men in the United States (0.9). Sixteen of the 134 males with FD reported oligospermia, which suggests that an infertility work up may be indicated for males having difficulty impregnating their partners. In our large multicenter sample, males and females with FD do not exhibit reduced reproductive fitness; on average they have more biological children than the general population in the United States. This information should assist clinicians in providing accurate reproductive genetic counseling and treatment for individuals with FD.

Entities:  

Year:  2017        PMID: 28324326      PMCID: PMC5740039          DOI: 10.1007/8904_2017_17

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  47 in total

1.  Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria.

Authors:  Thomas P Mechtler; Susanne Stary; Thomas F Metz; Víctor R De Jesús; Susanne Greber-Platzer; Arnold Pollak; Kurt R Herkner; Berthold Streubel; David C Kasper
Journal:  Lancet       Date:  2011-11-29       Impact factor: 79.321

2.  Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia.

Authors:  M W Spence; J T Clarke; D M D'Entremont; G A Sapp; E R Smith; A L Goldbloom; G Davar
Journal:  J Med Genet       Date:  1978-12       Impact factor: 6.318

3.  Frequency of azoospermia.

Authors:  G M Willott
Journal:  Forensic Sci Int       Date:  1982 Jul-Aug       Impact factor: 2.395

4.  [Priapism: a severe paediatric complication of Fabry disease].

Authors:  F Labarthe; C de Bodman; A Maruani; C Szwarc; R Froissart; G Lorette; H Lardy
Journal:  Rev Med Interne       Date:  2010-12       Impact factor: 0.728

5.  Testicular and epididymal involvement in Fabry's disease.

Authors:  M Nistal; R Paniagua; M L Picazo
Journal:  J Pathol       Date:  1983-10       Impact factor: 7.996

6.  Social-adaptive and psychological functioning of patients affected by Fabry disease.

Authors:  Dawn Alyssia Laney; Daniel J Gruskin; Paul M Fernhoff; Joseph F Cubells; Opal Y Ousley; Heather Hipp; Ami J Mehta
Journal:  J Inherit Metab Dis       Date:  2010-01-20       Impact factor: 4.982

Review 7.  World Health Organization reference values for human semen characteristics.

Authors:  Trevor G Cooper; Elizabeth Noonan; Sigrid von Eckardstein; Jacques Auger; H W Gordon Baker; Hermann M Behre; Trine B Haugen; Thinus Kruger; Christina Wang; Michael T Mbizvo; Kirsten M Vogelsong
Journal:  Hum Reprod Update       Date:  2009-11-24       Impact factor: 15.610

8.  Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study.

Authors:  Takahito Inoue; Kiyoko Hattori; Kenji Ihara; Atsushi Ishii; Kimitoshi Nakamura; Shinichi Hirose
Journal:  J Hum Genet       Date:  2013-05-16       Impact factor: 3.172

9.  Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry.

Authors:  Stephen Waldek; Manesh R Patel; Maryam Banikazemi; Roberta Lemay; Philip Lee
Journal:  Genet Med       Date:  2009-11       Impact factor: 8.822

10.  Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease.

Authors:  Dominique P Germain; Joel Charrow; Robert J Desnick; Nathalie Guffon; Judy Kempf; Robin H Lachmann; Roberta Lemay; Gabor E Linthorst; Seymour Packman; C Ronald Scott; Stephen Waldek; David G Warnock; Neal J Weinreb; William R Wilcox
Journal:  J Med Genet       Date:  2015-03-20       Impact factor: 6.318

View more
  1 in total

1.  Semen and male genital tract characteristics of patients with Fabry disease: the FERTIFABRY multicentre observational study.

Authors:  Aline Papaxanthos-Roche; Aline Maillard; Lucie Chansel-Debordeaux; Martine Albert; Catherine Patrat; Olivier Lidove; Dominique P Germain; Paul Perez; Didier Lacombe
Journal:  Basic Clin Androl       Date:  2019-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.